Clark County Disease Statistics* Third Quarter, 2014

201220132014Rate(Cases per 100,000 per quarter)Quarterly Rate Comparison
DiseaseQ3
No.
YTD
No.
Q3
No.
YTD
No.
Q3
No.
YTD
No.
Qtr3
(2009-2013 aggregated)
Qtr3
(2014)
Significant change bet.
current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA0000000.000.00
HAEMOPHILUS INFLUENZA (INVASIVE)110085110.080.25
HEPATITIS A05412140.120.05
HEPATITIS B (ACUTE)6205181130.330.05X
INFLUENZA**536165151151310.770.54X
MEASLES0000000.020.00
MUMPS0011120.030.05
PERTUSSIS3765411105450.940.25X
POLIOMYELITIS0000000.000.00
RUBELLA0000000.000.00
TETANUS0000000.000.00
SEXUALLY TRANSMITTED
AIDS4615254160451602.632.21
CHLAMYDIA215264512489708319586087115.8696.37X
GONORRHEA55414316021654593163325.9829.19
HIV4616478203672143.113.30
SYPHILIS (EARLY LATENT)4713557165692142.223.40X
SYPHILIS (PRIMARY & SECONDARY)256554116511791.692.51
ENTERICS
AMEBIASIS2526110.080.05
BOTULISM-INTESTINAL (INFANT)0000000.000.00
CAMPYLOBACTERIOSIS2267317032771.441.57
CHOLERA0000000.000.00
CRYPTOSPORIDIOSIS1436020.160.00X
GIARDIA265217447250.990.34X
ROTAVIRUS19515815470.580.25
SALMONELLOSIS501214732846892.602.26
SHIGA-TOXIN PRODUCING E. COLI#173619428160.650.39
SHIGELLOSIS304227399181.250.44X
TYPHOID FEVER0100020.030.00
VIBRIO (NON-CHOLERA)3313010.090.00X
YERSINIOSIS0147010.040.00
OTHER
ANTHRAX0000000.000.00
BOTULISM INTOXICATION0000000.000.00
BRUCELLOSIS0000000.000.00
COCCIDIOIDOMYCOSIS278917548440.910.39
DENGUE FEVER1101020.050.00X
ENCEPHALITIS1102110.010.05
HANTAVIRUS0000000.000.00
HEMOLYTIC UREMIC SYNDROME (HUS)0000010.000.00
HEPATITIS C (ACUTE)0413010.010.00
HEPATITIS D0000000.000.00
INVASIVE GROUP A STREP.##0000000.010.00
LEGIONELLOSIS51181510160.240.49
LEPROSY (HANSEN’S DISEASE)0000010.000.00
LEPTOSPIROSIS0000000.000.00
LISTERIOSIS0112030.020.00
LYME DISEASE0357230.060.10
MALARIA0125350.080.15
MENINGITIS, ASEPTIC/VIRAL614193512310.560.59
MENINGITIS, BACTERIAL1316390.100.15
MENINGOCOCCAL DISEASE0200020.020.00
PLAGUE0000000.000.00
PSITTACOSIS0000000.000.00
Q FEVER0000000.020.00
RABIES (HUMAN)0000000.000.00
RELAPSING FEVER0000000.000.00
ROCKY MOUNTAIN SPOTTED FEVER0000000.000.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)14790111177186111.850.89X
STREPTOCOCCUS PNEUMONIAE, IPD###53494115640.330.74
TOXIC SHOCK SYN0000000.000.00
TOXIC SHOCK SYN (STREPTOCOCCAL)0313190.010.05
TUBERCULOSIS1654195820561.000.98
TULAREMIA0000000.000.00
UNUSUAL ILLNESS0000000.000.00
WEST NILE VIRUS (ENCEPHALITIS)4448220.230.10
WEST NILE VIRUS (FEVER)2201000.050.00X

 

*Rate denominators were spline-interpolated population estimates/projections based on demographic data subject to ongoing revision by the state demographer (last revision as of Oct-2013). Use of onset date to count OOE-reported cases (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS case counts provided by Office of HIV/AIDS/STD; TB case counts provided by TB clinic. Quarterly disease total reported by OOE=207(reported total=3010). Due to unavailability of current birth data, congenital syphilis rates were not calculated(reported quarterly cases for 2012-2014 were respectively 0,0,1; YTD totals 0,2,2).

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).

 

Updated on:  October 9, 2018

2018-10-09T09:57:23-07:00